[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
December 2014

The US Food and Drug Administration’s Efforts to Support Ophthalmology Clinical Trials

Author Affiliations
  • 1Division of Ophthalmic and Ear, Nose, and Throat Devices, Office of Device Evaluation, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland
JAMA Ophthalmol. 2014;132(12):1391-1392. doi:10.1001/jamaophthalmol.2014.2826

The role of the US Food and Drug Administration (FDA) is to protect public health—keeping unsafe medical devices off the market, exposing potentially dangerous devices that carry fraudulent claims to cure or treat disease, and investigating potential and emerging health and safety issues related to medical devices in the United States. However, while protecting public health is critical to our mission, promoting public health is just as important. Part of promoting public health is facilitating the development of innovative technology and making sure patients have access to high-quality, safe, and effective medical devices as quickly as possible.

First Page Preview View Large
First page PDF preview
First page PDF preview
×